ArticleEuropean archives of psychiatry and clinical neuroscience2026
Integrated multi-omics and functional analyses reveal a GDCA-TGR5-mediated immunometabolic signature in anorexia nervosa.
Article in European archives of psychiatry and clinical neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundAnorexia nervosa (AN) is frequently accompanied by metabolic disturbances and immune dysregulation, yet its peripheral molecular mechanisms and therapeutic targets remain poorly understood. This study integrates multi-omics analyses with experimental validation to investigate causal relationships between circulating metabolites and immune features in AN.
methodsTwo-sample Mendelian randomization (MR) analyses based on two independent cohorts were conducted to screen metabolism- and immune-related factors associated with AN. Differential expression analysis combined with machine learning was used to identify core pathogenic genes and immune infiltration patterns, which were cross-validated with MR results. The immunoregulatory role of the core gene G protein-coupled bile acid receptor 1 (GPBAR1, also known as TGR5) was further validated in vitro using mouse bone marrow-derived macrophages (BMDMs) treated with the bile acid metabolite glycodeoxycholic acid (GDCA).
resultsMR analysis revealed significant causal associations between eight circulating metabolites, multiple immune cell traits, and AN. Integrated transcriptomic and machine learning analyses identified TGR5 as a key gene associated with AN. Functional enrichment and immune infiltration analyses indicated that AN is characterized by an immunosuppressive microenvironment, closely correlated with TGR5 expression and activation of the primary bile acid biosynthesis pathway. Molecular docking predicted a stable interaction between GDCA and TGR5. In vitro experiments showed that GDCA increased the proportion of CD206
conclusionsThese findings suggest that metabolic alterations in AN directly influence immune regulation. Activation of the GDCA/TGR5/cAMP/PKA/STAT3/6 axis promotes M2 macrophage polarization and anti-inflammatory responses, revealing a novel metabolic-immune pathway with therapeutic potential in AN.
Indexed as
Identifiers
42658241What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.